Literature DB >> 28782992

PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis.

Dongmei Wang1,2,3, Jiangyong Gu1,2, Wei Zhu1,2, Fang Luo4, Lirong Chen4, Xiaojie Xu2,4, Chuanjian Lu1,2,5.   

Abstract

INTRODUCTION: Psoriasis is a refractory skin disorder, and usually requires a lifetime control. Traditional Chinese medicine (TCM) is effective and safe for this disease. However, the cellular and molecular mechanisms of TCM remedies for psoriasis are still not fully understood. TCM contains numerous natural products. Natural products have historically been invaluable as a resource of therapeutic agents. Yet, there is no integrated information about active compounds of TCM for psoriasis.
METHOD: We use systems pharmacology methods to develop the Psoriasis Database of Traditional Chinese Medicine (PDTCM). The database covered a number of psoriasis-related information (formulas, TCM, compounds, target proteins, diseases and biomarkers). With these data information, an online platform was constructed
Results: PDTCM comprises 38 empirical therapeutic formulas, 34373 compounds from 1424 medicinal plants, 44 psoriasis-related proteins and 76 biomarkers from 111 related diseases. On this platform, users can screen active compounds for a psoriasis-related target and explore molecular mechanisms of TCM. Accordingly, users can also download the retrieved structures and data information with a defined value set. In addition, it helps to get a better understanding of Chinese prescriptions in disease treatment.
CONCLUSION: With the systems pharmacology-based data, PDTCM would become a valuable resource for TCM in psoriasis-related research. Key messages PDTCM platform comprises a great deal of data on TCM and psoriasis. On this platform, users can retrieve and get needed information with systems pharmacology methods, such as active compounds screening, target prediction and molecular mechanisms exploration. It is a tool for psoriasis-related research on natural drugs systematically.

Entities:  

Keywords:  High throughput virtual screening; psoriasis; systems pharmacology; target prediction; traditional Chinese medicine

Mesh:

Substances:

Year:  2017        PMID: 28782992     DOI: 10.1080/07853890.2017.1364417

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

1.  Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer.

Authors:  Zhen Zhang; Jun-Wei Li; Pu-Hua Zeng; Wen-Hui Gao; Xue-Fei Tian
Journal:  Chin J Integr Med       Date:  2021-08-25       Impact factor: 1.978

2.  Intervention Mechanism of Hunag-Lian Jie-Du Decoction on Canonical Wnt/β-Catenin Signaling Pathway in Psoriasis Mouse Model.

Authors:  Xuesong Yang; Guangyun Luo; Lan Fu; Hong Huang; Lifen Wang; Lihua Yin; Xuelian Zhang; Tingting Wang; Xuan Ma; Tianyu Feng; Jianzhou Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

3.  Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis.

Authors:  Guangyao Li; Yuan Zhou; Daniel Man-Yuen Sze; Chao Liu; Qianru Zhang; Zihao Wang; Hua Yu; Ging Chan; Zhongdao Wu; Shibing Su; Yuanjia Hu
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-03       Impact factor: 2.629

4.  Circulating CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome.

Authors:  Shipeng Sun; Yali Wei; Xue Zeng; Yuliang Yuan; Na Wang; Cheng An; Jinlong Duan; Bo Pang; Zifu Hong; Guijian Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-14       Impact factor: 2.629

5.  Chinese Medicine for Psoriasis Vulgaris Based on Syndrome Pattern: A Network Pharmacological Study.

Authors:  Dongmei Wang; Chuanjian Lu; Jingjie Yu; Miaomiao Zhang; Wei Zhu; Jiangyong Gu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.